Clinical Trials Directory

Trials / Completed

CompletedNCT03697928

Markers of Carnitine Acetyltransferase (CrAT) Protein Activity and Carnitine Availability

Searching for Non-invasive Magnetic Resonance-based Markers for CrAT Protein Activity and Carnitine Availability in Skeletal Muscle

Status
Completed
Phase
Study type
Observational
Enrollment
13 (actual)
Sponsor
Maastricht University · Academic / Other
Sex
Male
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study aims to measure skeletal muscle metabolism in vivo during exercise using the non-invasive Magnetic Resonance Spectroscopy (MRS) technique. Specifically, phosphocreatine (PCr) kinetic and Acetylcarnitine levels will be determined at resting, during exercise and during the recovery post exercise. The target population is adult healthy men, with a wide range of maximal physical capacity.

Detailed description

Skeletal muscle mitochondrial activation during the transition from resting metabolism to exercise may modulated by CrAT activity. Furthermore, dynamic changes in acetylcarnitine during the transition from exercise to resting metabolism (acetylcarnitine off-kinetic) may also reflect the action of CrAT protein. To date, the only possibility to get information on CrAT activity is by taking a muscle biopsy and perform enzyme activity assays ex vivo. By dynamic MRS scanning, it might be possible to deduce information that reflects CrAT activity, thereby making the biopsy sampling unnecessary.

Conditions

Interventions

TypeNameDescription
OTHERExercise metabolismParticipants will perform a series of exercises inside and outside the MRS/MRI scanner.

Timeline

Start date
2019-03-12
Primary completion
2020-02-01
Completion
2020-02-01
First posted
2018-10-05
Last updated
2020-10-19

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03697928. Inclusion in this directory is not an endorsement.